Results 321 to 330 of about 362,575 (339)

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Nature Reviews Drug Discovery, 2010
Harald Hampel, Stefan J Teipel, John Hardy   +2 more
exaly  

Alzheimer's disease: strategies for disease modification

Nature Reviews Drug Discovery, 2010
Martin Citron
exaly  

Alzheimer's Disease

New England Journal of Medicine, 2004
openaire   +2 more sources

Drug repositioning for Alzheimer's disease

Nature Reviews Drug Discovery, 2012
Anne Corbett, James A Pickett, Alistair Burns   +2 more
exaly  

Alzheimer Disease

1998
openaire   +2 more sources

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Nature Reviews Drug Discovery, 2011
Eric Karran, Bart De Strooper
exaly  

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Nature Reviews Immunology, 2018
Yang Shi, David M Holtzman
exaly  

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

Nature Reviews Drug Discovery, 2013
Bruno Vellas, Harald Hampel
exaly  

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

New England Journal of Medicine, 2012
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger   +2 more
exaly  

A call for a global ‘bigger’ data approach to Alzheimer disease

Nature Reviews Drug Discovery, 2018
Eric Perakslis, Emilio Merlo Pich
exaly